maysiglu 50 mg/1 tableta filmom obložena tableta
krka farma d.o.o. sarajevo - sitagliptin - filmom obložena tableta - 50 mg/1 tableta - 1 filmom obložena tableta sadrži: 50 mg sitagliptina
maysiglu 100 mg/1 tableta filmom obložena tableta
krka farma d.o.o. sarajevo - sitagliptin - filmom obložena tableta - 100 mg/1 tableta - 1 filmom obložena tableta sadrži: 100 mg sitagliptina
maysiglu 100 mg/1 tableta filmom obložena tableta
krka farma d.o.o. sarajevo - sitagliptin - filmom obložena tableta - 100 mg/1 tableta - 1 filmom obložena tableta sadrži: 100 mg sitagliptina
sitagliptin zentiva 100 mg filmom obložene tablete
zentiva k.s., u kabelovny 130, dolni mecholupy, prag 10, Češka - sitagliptinklorid hidrat - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži sitagliptinklorid hidrat što odgovara 100 mg sitagliptina
sitagliptin zentiva 25 mg filmom obložene tablete
zentiva k.s., u kabelovny 130, dolni mecholupy, prag 10, Češka - sitagliptinklorid hidrat - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži sitagliptinklorid hidrat što odgovara 25 mg sitagliptina
sitagliptin zentiva 50 mg filmom obložene tablete
zentiva k.s., u kabelovny 130, dolni mecholupy, prag 10, Češka - sitagliptinklorid hidrat - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži sitagliptinklorid hidrat što odgovara 50 mg sitagliptina
sitagliptin sun
sun pharmaceutical industries europe b.v. - sitagliptin fumarate - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - for adult patients with type 2 diabetes mellitus, sitagliptin sun is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. a thiazolidinedione) when use of a pparγ agonist is appropriate and when diet and exercise plus the pparγ agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a pparγ agonist and metformin when use of a pparγ agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin sun is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.
sigazix 100 mg filmom obložene tablete
jadran galenski laboratorij d.d., svilno 20, rijeka, hrvatska - sitagliptinklorid hidrat - filmom obložena tableta - urbroj: jedna tableta sadrži 100 mg sitagliptina u obliku sitagliptinklorid hidrata
sigazix 50 mg filmom obložene tablete
jadran galenski laboratorij d.d., svilno 20, rijeka, hrvatska - sitagliptinklorid hidrat - filmom obložena tableta - urbroj: jedna tableta sadrži 50 mg sitagliptina u obliku sitagliptinklorid hidrata
sitagliptin grindeks 100 mg filmom obložene tablete
as grindeks, krustpils iela 53, riga, latvija - sitagliptinklorid hidrat - filmom obložena tableta - urbroj: svaka filmom obložena tableta sadrži 100 mg sitagliptina u obliku sitagliptinklorid hidrata